Skip to main content

ORIGINAL RESEARCH article

Front. Cell Dev. Biol., 14 October 2024
Sec. Molecular and Cellular Pathology
This article is part of the Research Topic Artificial Intelligence Applications in Chronic Ocular Diseases, Volume II View all 11 articles

Development of a transformer-based deep learning algorithm for diabetic peripheral neuropathy classification using corneal confocal microscopy images

Wenqu Chen&#x;Wenqu ChenDanling Liao&#x;Danling LiaoYuyang Deng&#x;Yuyang DengJianzhang Hu
Jianzhang Hu*
  • Department of Ophthalmology, Fujian Medical University Union Hospital, Fu Zhou, China

Background: Diabetic peripheral neuropathy (DPN) is common and can go unnoticed until it is firmly developed. This study aims to establish a transformer-based deep learning algorithm (DLA) to classify corneal confocal microscopy (CCM) images, identifying DPN in diabetic patients.

Methods: Our classification model differs from traditional convolutional neural networks (CNNs) using a Swin transformer network with a hierarchical architecture backbone. Participants included those with (DPN+, n = 57) or without (DPN−, n = 37) DPN as determined by the updated Toronto consensus criteria. The CCM image dataset (consisting of 570 DPN+ and 370 DPN− images, with five images selected from each participant’s left and right eyes) was randomly divided into training, validation, and test subsets at a 7:1:2 ratio, considering individual participants. The effectiveness of the algorithm was assessed using diagnostic accuracy measures, such as sensitivity, specificity, and accuracy, in conjunction with Grad-CAM visualization techniques to interpret the model’s decisions.

Results: In the DPN + group (n = 12), the transformer model successfully predicted all participants, while in the DPN− group (n = 7), one participant was misclassified as DPN+, with an area under the curve (AUC) of 0.9405 (95% CI 0.8166, 1.0000). Among the DPN + images (n = 120), 117 were correctly classified, and among the DPN− images (n = 70), 49 were correctly classified, with an AUC of 0.8996 (95% CI 0.8502, 0.9491). For single-image predictions, the transformer model achieved a superior AUC relative to the ResNet50 model (0.8761, 95% CI 0.8155, 0.9366), the Inception_v3 model (0.8802, 95% CI 0.8231, 0.9374), and the DenseNet121 model (0.8965, 95% CI 0.8438, 0.9491).

Conclusion: Transformer-based networks outperform CNN-based networks in rapid binary DPN classification. Transformer-based DLAs have clinical DPN screening potential.

Introduction

Diabetic peripheral neuropathy (DPN), which affects more than half of people with diabetes, is the most common complication of this disease (Dyck et al., 1999; Pop-Busui et al., 2017). However, the subtle signs of this condition can go unnoticed until it is firmly developed and irreversible (Dyck et al., 2011). Early detection of diabetic neuropathy is vital to halt its progression and reduce the associated morbidity and mortality risks (Alam et al., 2017; Iqbal et al., 2018). Presently, the primary method for screening for DPN is the 10 g monofilament test. The 10 g monofilament test involves applying a standardized nylon monofilament to various points on the foot to assess the patient’s ability to feel pressure, serving as a simple screening tool for detecting loss of protective sensation (Kumar et al., 1991). However, this method relies on the subjective response of patients and is limited in its effectiveness in detecting small fibers initially affected by DPN (Dyck and Giannini, 1996; Richard et al., 2014; Ziegler et al., 2014). Evaluating small-fiber function often requires an invasive skin biopsy (Lauria et al., 2009). Straightforward indicators for identifying DPN early are lacking in clinical practice (Selvarajah et al., 2019).

Growing evidence supports the value of corneal confocal microscopy (CCM) in detecting DPN. CCM offers a swift, noninvasive method to precisely and objectively measure changes in the corneal subbasal nerve plexus in diabetic patients (Chen et al., 2015; Liu Y.-C. et al., 2021). In DPN, CCM reveals significant alterations in nerve fibers, including a reduction in nerve fiber density, changes in morphology characterized by thinner and more tortuous fibers, and a loss of nerve branching (Yu et al., 2022). These changes collectively indicate nerve damage and degeneration, serving as critical markers for the assessment of neuropathy severity. It is highly reproducible and can detect small fiber function (Devigili et al., 2019; Li et al., 2019). Moreover, it demonstrates high sensitivity and specificity in quantifying early damage in DPN patients (Petropoulos et al., 2013; 2014; Williams et al., 2020; Roszkowska et al., 2021) and can predict the occurrence of diabetic neuropathy (Pritchard et al., 2015). This approach is a reliable and noninvasive alternative to skin biopsy (Ferdousi et al., 2021; Perkins et al., 2021). However, despite its advantages, the CCM is not currently used for clinical screening for DPN in patients. This is because large prospective studies are needed to confirm the reliability of CCM (Sloan et al., 2021), and it is essential to ensure precise feature extraction from CCM images.

In the past decade, artificial intelligence (AI), primarily deep learning, has become widely used in clinical diabetic retinopathy screening, significantly reducing the demands on screening resources (Rajesh et al., 2023). AI models for diagnosing DPN from CCM images have shown promising results. Dabbah et al. (2011) developed a dual-model system for automated detection that can extract nerve fibers from CCM images. They improved the automated software by employing dual-model properties across multiple scales, achieving performance levels similar to manual annotation (Chen et al., 2017). The model, which lacks convolutional layers, necessitates additional data preprocessing and may lead to overfitting during the training process, thus imposing constraints on its performance. Convolutional neural networks (CNNs), a branch of deep learning, achieve “end-to-end” classification without requiring specific instance parameters (LeCun et al., 2015). It has excelled in the automatic analysis of CCM images. Preston et al. (2022) introduced an approach for classifying peripheral neuropathy that eliminates the need for nerve segmentation, which refers to the process of isolating and identifying individual nerve fibers in images for analysis. Additionally, they integrated attribution techniques to provide transparency and interpretation of the decision-making process. However, efficiently and accurately obtaining corneal nerve features from CCM images remains one of the most challenging issues in the intelligent analysis of CCM images. We have noted that another deep learning algorithm (DLA), the Swin transformer network, has shown strong performance in image classification (Liu Z. et al., 2021). The Swin transformer network is a type of transformer architecture that utilizes a hierarchical design, allowing it to effectively process images at multiple resolutions. Unlike CNNs, the Swin transformer employs a unique shifted window mechanism for self-attention, which enables efficient information capture across different parts of the image while maintaining computational efficiency. However, its application in classifying CCM images has not been reported.

In this study, we used a transformer-based DLA to classify CCM images for detecting DPN. We aimed to confirm the feasibility of the transformer architecture for CCM image classification tasks by comparing it with traditional CNN models.

Methods

Participants

Ninety-four participants diagnosed with diabetes mellitus (DM) underwent assessment for the presence (DPN+, n = 57) or absence (DPN−, n = 37) of DPN based on the updated Toronto consensus criteria (Table 1). These criteria require evidence of neuropathy, along with at least one abnormality in two nerve electrophysiology parameters: peripheral nerve amplitude and peripheral nerve conduction velocity (Tesfaye et al., 2010). Participants were recruited from outpatients of Fujian Medical University Union Hospital, Fuzhou, China, 2024/01–2024/06. Before any assessments took place, all participants provided informed and valid consent. Each participant underwent comprehensive neuropathy and CCM evaluation. Those who had experienced neuropathy in the past (excluding diabetes), had current or recurring diabetic foot ulcers, lacked sufficient vitamin B12 or folate, had a history of corneal disease or surgery, or wore contact lenses were not included in the study. The research adhered to the Declaration of Helsinki, and approval from ethical and institutional bodies was secured prior to participants beginning the study. Ethics approval was obtained from the Ethics Committee of Fujian Medical University Union Hospital (NO. 2024KY112).

Table 1
www.frontiersin.org

Table 1. Demographic and clinical profiles of participants with DM.

Image dataset

The dataset consists of corneal subbasal nerve plexus images of diabetic individuals. The images were obtained at a resolution of 400 × 400 μm with a confocal laser microscope (Heidelberg Engineering, Heidelberg, Germany). Images were acquired from the central cornea at the subbasal nerve plexus using section mode, capturing each image at a resolution of 400 × 400 μm (384 × 384 pixels). The images were exported in JPEG file format. During imaging, participants’ heads were fixed, and they were instructed to gaze straight ahead, ensuring that the laser reflection point remained at the center of the cornea. During data collection, the CCM of each participant yielded a spectrum of 20 to 40 digital images per eye. After a rigorous screening by medical experts (JZH and WQC), which involved excluding images marred by blurriness or captured from regions deemed inappropriate, quintets of images per eye were meticulously selected for analytical purposes. The selection was based on the following principles: first, the images had to be of high quality with good contrast and clearly visible nerves; second, they were selected from the central cornea; and third, we aimed to represent a range of corneal nerve densities, choosing images that showed the lowest to the highest density (Kalteniece et al., 2017). The final dataset consisted of images from individuals diagnosed with DPN (n = 570) and individuals diagnosed without DPN (n = 370).

Dataset preparation

The dataset was arbitrarily stratified among training, validation, and test subsets following a proportion of 7:1:2, anchored on individual participants. The data were divided according to the original distribution ratio, consisting of 660 for the training set (DPN+ 400, DPN− 260), 90 for the validation set (DPN+ 50, DPN− 40), and 190 for the test set (DPN+ 120, DPN- 70). The training set was utilized for model data training and parameter adjustment, and the validation set was employed to assess the effect in the training phase. The test set data were utilized to assess the final effectiveness of the model.

Before being input into the model, the images underwent preprocessing operations. We resized images from 384 × 384 pixels to 224 × 224 pixels using the bilinear interpolation method to meet the input specifications of the model. We normalized the values to [−1, 1] using a mean of 0.5 and a standard deviation of 0.5 across the three channels during image input to optimize training.

Network architecture and different backbone

Our classification model employs the Swin transformer network (Liu Z. et al., 2021) as its backbone (Figure 1). Compared to the traditional CNN, the transformer structure introduces a hierarchical architecture that processes features at different resolutions by training the image in small patches. The self-attention computation of the transformer is confined to fixed-size local windows. The Swin transformer leverages a shifted window mechanism, alternating the positions of these windows in adjacent layers, enabling the model to capture information across windows while avoiding the high computational cost of global self-attention. After obtaining 1024-dimensional features extracted by the network, we added a compact stratum with 512 neurons, sequenced by a dropout layer featuring a rate of 0.7. Finally, the features passed through a binary dense layer, and the softmax activation function was used to output the binary classification result. The network continued training on the basis of pretrained model weights from ImageNet1000 (Deng et al., 2009).

Figure 1
www.frontiersin.org

Figure 1. Diagram of the DLA based on the modified Swin transformer network. Each blue block represents patch merging, which is primarily employed to adjust the dimensionality of the input after initial segmentation into patches. Each orange block represents a Swin transformer block, which utilizes a concatenation of multihead self-attention and shifted windowing multihead self-attention mechanisms to facilitate information exchange among small patches. The black block represents the subsequent classifier, which comprises dense and dropout layers, to obtain the final classification probabilities. In the DLA network, a single-image input generates image-level predictions. Probabilities from multiple images belonging to the same participant were weighted averaged to obtain participant-level predictions.

In the model configuration for the Swin Transformer, the patch size is set to 4, and the window size is set to 7. The base model has an embedding dimension of 128, with the depth of each Swin Transformer block set to 2, 2, 18, and 2, and the number of heads set to 4, 8, 16, and 32, respectively. For the tiny model, the embedding dimension is set to 96, with the depth of each block configured as 2, 2, 9, and 2, and the number of heads as 3, 6, 12, and 24, respectively. During the model training process, the batch size was set to 32, and the Stochastic Gradient Descent optimizer was employed. The initial learning rate was set to 0.005, and the learning rate scheduler used was CosineAnnealingLR. Cross-entropy loss was chosen as the loss function, and the model was trained for 150 epochs.

We also selected other models for training to compare their effectiveness. ResNet50 (He et al., 2016), DenseNet121 (Huang et al., 2018), and InceptionV3 (Szegedy et al., 2016) were selected as different backbone networks for training. These network structures are all based on the CNN architecture. The experimental training settings remained consistent except for changes in the input size of the individual networks.

The results were generated using a PC featuring an Intel Core i7-13700K processor with 32 GB of RAM and an Nvidia GeForce RTX 4070 Ti. The model was formulated and trained using Python 3.9 and PyTorch 2.0.0.

Performance evaluation

Each model generated a respective confusion matrix, elucidating the discrepancy between the actual classification of images and the predictions rendered by the model. A suite of standard metrics derived from the confusion matrix for evaluating classification models was computed, encompassing accuracy, sensitivity, specificity, and the F1 score.

Accuracy is determined as the ratio of accurate predictions to the overall number of predictions.

Recall, also called sensitivity, represents the number of predicted positives relative to the total number of actual positives.

Precision is defined as the ratio of true positive instances among all predicted positives, which gauges the impact of false positives.

F1-score is a statistical measure that represents the harmonic mean of precision and recall, balancing the trade-off between these two metrics. It offers a more comprehensive evaluation of model performance compared to using accuracy alone (Sokolova and Lapalme, 2009).

Area Under the Curve (AUC) is a crucial metric for evaluating classification models. It quantifies the model’s ability to distinguish between classes, summarizing the trade-offs between sensitivity and specificity at various thresholds. A higher AUC value indicates better model performance in differentiating between the positive and negative classes, making it an essential indicator of a model’s potential effectiveness in clinical settings.

Grad-CAM technology (Selvaraju et al., 2020) is employed to visualize the areas within images that the model prioritizes for decision-making, offering insights into the model’s interpretability.

Given that five images were taken from each participant from both the left and right eyes, with each image yielding a binary probability output, the evaluation of the model efficacy in discerning the status of participants necessitates a comprehensive approach. Therefore, the probability outputs associated with all images from a single participant are combined through a weighted mean calculation. A patient is defined as DPN + when the weighted mean of DPN+ is greater than that of DPN−, and as DPN− when the weighted average of DPN+ is less than or equal to that of DPN−. The final output serves as the criterion for assessment at the participant level.

Results

The confusion matrix table generated from the test set using the Swin transformer network as the prediction model for backbone network training is shown in Tables 2, 3. Among the DPN + patients (n = 12), the model successfully predicted all participants. According to the single-image confusion matrix, 117 DPN + images (n = 120) were accurately categorized, and 3 images were inaccurately categorized as DPN−.

Table 2
www.frontiersin.org

Table 2. Single-image confusion matrix from the Swin transformer network.

Table 3
www.frontiersin.org

Table 3. Single-participant confusion matrix from the Swin transformer network.

The performance indicators for a single image are shown in Table 4. The network trained with the Swin transformer architecture reached the highest accuracy of 0.8789, in contrast to other classification networks. The best F1 score was 0.9084, and the highest recall was 0.9500. The AUC reached 0.8996 (0.8502, 0.9491). Overall, the networks based on the transformer architecture achieved superior results.

Table 4
www.frontiersin.org

Table 4. Single-image and single-participant classification indicators.

The performance indicators for a single participant are shown in Table 4. Apart from the area beneath the ROC curve, all other model performance metrics align with our proposed model. The overall classification accuracy reached 0.8947, with the AUC achieving an even higher value of 0.9405 (0.8166, 1.0000). Figure 2 depicts the AUC performance of our suggested method, delineated separately for the training and test subsets across a single participant.

Figure 2
www.frontiersin.org

Figure 2. ROC curve analysis for detecting DPN using training and test subsets from a single participant.

Figure 3 presents the various CCM images within the test set across distinct models, alongside the Grad-CAM images generated for each case. The networks based on the transformer architecture tend to exhibit more refined detail in the regions identified for image judgment during the presentation process than those based on CNN architectures.

Figure 3
www.frontiersin.org

Figure 3. Grad-CAM images of DPN+ (left 3 columns) and DPN− (right 3 columns) patients accurately detected using the transformer and CNN models. Upper section, original images; center section, transformer Grad-CAM images; lower section, CNN Grad-CAM images.

Discussion

In our research, we employed an advanced DLA to analyze CCM images of corneal nerves, simulating a clinical screening environment, to distinguish diabetic patients with DPN from the diabetic population. The algorithm performed well in this binary classification task without requiring nerve segmentation (AUC 0.9405; sensitivity 0.8947; specificity 0.9167), highlighting its clinical utility in accurately identifying DPN patients. Our experiments showed that in classifying DPN using deep learning networks, networks based on transformer architectures outperform those based on CNN architectures.

Current clinical criteria of DPN typically include a combination of clinical history, physical examination, and nerve electrophysiology, but they often fail to capture the nuances of nerve damage early on (Atmaca et al., 2024). Timely detection and assessment of small nerve fiber damage is key to screening for DPN. CCM, as a non-invasive examination method, can provide accurate biomarkers for small nerve fiber damage (Carmichael et al., 2022).

Some studies have utilized AI-based CNN approaches to analyze corneal nerve images to classify DPN patients (Scarpa et al., 2020; Williams et al., 2020; Salahouddin et al., 2021; Preston et al., 2022; Meng et al., 2023). Williams et al. (2020) employed a U-Net CNN architecture for analyzing and quantifying corneal nerves, achieving an AUC of 0.83, specificity of 0.87, and sensitivity of 0.68 in distinguishing DPN + patients. Preston et al. (2022) utilized a ResNet-50-based CNN to classify corneal nerve images for DPN, attaining a recall of 0.83, precision of 1.0, and an F1 score of 0.91. Salahouddin et al. (2021) employed a U-Net-based CNN to distinguish individuals with DPN from those without DPN, demonstrating a sensitivity of 0.92, a specificity of 0.8, and an AUC of 0.95. Meng et al. (2023) utilized a modified ResNet-50 CNN to achieve dichotomous classification between DPN+ and DPN− patients, with a sensitivity of 0.91, a specificity of 0.93, and an AUC of 0.95.

In contrast to previous CNN-based models, our study utilizes the Swin transformer as the backbone network for training. In our research, the models generally demonstrated superior performance, as evidenced by higher AUC values than those trained with traditional architectures. The Grad-CAM visualizations further revealed that Swin transformer-based models excel in identifying nuanced details of neural components, indicating that they extract features with greater precision and depth than conventional CNN architectures. Our approach, which contrasts with analogous binary classification methods, is more advanced and demonstrates enhanced sensitivity. The pronounced recall of the model indicates an enhanced sensitivity toward detecting neurological abnormalities, notwithstanding the possibility of misdiagnosis in certain instances. This heightened sensitivity is pivotal in minimizing the likelihood of overlooking such conditions, thereby rendering the model exceptionally beneficial for preliminary screenings.

Due to the limited coverage of each corneal image, individual images may offer incomplete representations of the overall corneal nerve. Relying solely on a single image might not provide a sufficiently comprehensive depiction for an accurate diagnosis. Scarpa et al. (2020) simulated the clinical decision-making process by utilizing multiple corneal nerve images from a single eye to assess DPN, which supported this standpoint. In our study, aggregating the prediction outcomes from multiple images for classification led to an overall improvement in the composite metrics across all models. This indicates that integrating judgments from multiple images yields more accurate results than relying on the assessment of a single image (Meng et al., 2023). This approach corresponds more with the judgments made in practical scenarios. Clinicians often find it difficult to make assessments based on a single image. This approach both improves the precision of model predictions and mirrors the nuanced decision-making process in clinical settings.

However, the sample size in our study, particularly for the DPN- group, is limited. A larger cohort would improve statistical power and generalizability. In addition, our model’s performance needs to be validated on external datasets to ensure its reliability. Given that data collection is a challenging process, we are concurrently gathering data from multiple centers.

Our DLA-based DPN screening method showed superior performance compared to the currently used monofilament tests (Wang et al., 2017), which demonstrated a sensitivity of 0.53 and specificity of 0.88. Despite the limitations of a smaller dataset, our study still attained a reasonable level of classification accuracy. There are currently no reports of AI-based CCM deployed in real-world settings for screening DPN. Based on previous experience, previous studies on diabetic retinopathy have suggested that AI performs less effectively in clinical practice than in laboratory validation (Kanagasingam et al., 2018). Therefore, large-scale prospective clinical studies are crucial for AI-based DPN screening.

Conclusion

The transformer-based networks demonstrated superior performance than traditional CNNs regarding rapid binary DPN classification. The transformer-based DLA offers a new direction for classifying DPN through automatic analysis of CCM images and holds potential for clinical screening.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by Ethics Committee of Fujian Medical University Union Hospital (NO. 2024KY112). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

WC: Data curation, Formal Analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing–original draft, Writing–review and editing. DL: Data curation, Formal Analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing–original draft, Writing–review and editing. YD: Data curation, Formal Analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing–original draft, Writing–review and editing. JH: Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Writing–review and editing.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by Joint Funds for the Innovation of Science and Technology, Fujian Province (Grant No. 2020Y9060).

Acknowledgments

Thanks to American Journal Experts for language-editing services.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Alam, U., Jeziorska, M., Petropoulos, I. N., Asghar, O., Fadavi, H., Ponirakis, G., et al. (2017). Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PloS One 12, e0180175. doi:10.1371/journal.pone.0180175

PubMed Abstract | CrossRef Full Text | Google Scholar

Atmaca, A., Ketenci, A., Sahin, I., Sengun, I. S., Oner, R. I., Erdem Tilki, H., et al. (2024). Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach. Front. Endocrinol. 15, 1380929. doi:10.3389/fendo.2024.1380929

CrossRef Full Text | Google Scholar

Carmichael, J., Fadavi, H., Ishibashi, F., Howard, S., Boulton, A. J. M., Shore, A. C., et al. (2022). Implementation of corneal confocal microscopy for screening and early detection of diabetic neuropathy in primary care alongside retinopathy screening: results from a feasibility study. Front. Endocrinol. 13, 891575. doi:10.3389/fendo.2022.891575

CrossRef Full Text | Google Scholar

Chen, X., Graham, J., Dabbah, M. A., Petropoulos, I. N., Ponirakis, G., Asghar, O., et al. (2015). Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care 38, 1138–1144. doi:10.2337/dc14-2422

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, X., Graham, J., Dabbah, M. A., Petropoulos, I. N., Tavakoli, M., and Malik, R. A. (2017). An automatic tool for quantification of nerve fibers in corneal confocal microscopy images. IEEE Trans. Biomed. Eng. 64, 786–794. doi:10.1109/TBME.2016.2573642

PubMed Abstract | CrossRef Full Text | Google Scholar

Dabbah, M. A., Graham, J., Petropoulos, I. N., Tavakoli, M., and Malik, R. A. (2011). Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging. Med. Image Anal. 15, 738–747. doi:10.1016/j.media.2011.05.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Deng, J., Dong, W., Socher, R., Li, L.-J., Li, K., and Fei-Fei, Li (2009). “ImageNet: a large-scale hierarchical image database,” in 2009 IEEE conference on computer vision and pattern recognition, (Miami, FL, 20–25 June 2009 (IEEE), 248–255. doi:10.1109/CVPR.2009.5206848

CrossRef Full Text | Google Scholar

Devigili, G., Rinaldo, S., Lombardi, R., Cazzato, D., Marchi, M., Salvi, E., et al. (2019). Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain J. Neurol. 142, 3728–3736. doi:10.1093/brain/awz333

PubMed Abstract | CrossRef Full Text | Google Scholar

Dyck, P. J., Albers, J. W., Andersen, H., Arezzo, J. C., Biessels, G.-J., Bril, V., et al. (2011). Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab. Res. Rev. 27, 620–628. doi:10.1002/dmrr.1226

PubMed Abstract | CrossRef Full Text | Google Scholar

Dyck, P. J., Davies, J. L., Wilson, D. M., Service, F. J., Melton, L. J., and O’Brien, P. C. (1999). Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22, 1479–1486. doi:10.2337/diacare.22.9.1479

PubMed Abstract | CrossRef Full Text | Google Scholar

Dyck, P. J., and Giannini, C. (1996). Pathologic alterations in the diabetic neuropathies of humans: a review. J. Neuropathol. Exp. Neurol. 55, 1181–1193. doi:10.1097/00005072-199612000-00001

PubMed Abstract | CrossRef Full Text | Google Scholar

Ferdousi, M., Kalteniece, A., Azmi, S., Petropoulos, I. N., Ponirakis, G., Alam, U., et al. (2021). Diagnosis of neuropathy and risk factors for corneal nerve loss in type 1 and type 2 diabetes: a corneal confocal microscopy study. Diabetes Care 44, 150–156. doi:10.2337/dc20-1482

PubMed Abstract | CrossRef Full Text | Google Scholar

He, K., Zhang, X., Ren, S., and Sun, J. (2016). Deep residual learning for image recognition. IEEE, 770–778. doi:10.1109/CVPR.2016.90

CrossRef Full Text | Google Scholar

Huang, G., Liu, Z., van der Maaten, L., and Weinberger, K. Q. (2018). Densely connected convolutional networks. IEEE Comput. Soc. doi:10.1109/CVPR.2017.243

CrossRef Full Text | Google Scholar

Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., et al. (2018). Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin. Ther. 40, 828–849. doi:10.1016/j.clinthera.2018.04.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Kalteniece, A., Ferdousi, M., Adam, S., Schofield, J., Azmi, S., Petropoulos, I., et al. (2017). Corneal confocal microscopy is a rapid reproducible ophthalmic technique for quantifying corneal nerve abnormalities. PLOS ONE 12, e0183040. doi:10.1371/journal.pone.0183040

PubMed Abstract | CrossRef Full Text | Google Scholar

Kanagasingam, Y., Xiao, D., Vignarajan, J., Preetham, A., Tay-Kearney, M.-L., and Mehrotra, A. (2018). Evaluation of artificial intelligence–based grading of diabetic retinopathy in primary care. JAMA Netw. Open 1, e182665. doi:10.1001/jamanetworkopen.2018.2665

PubMed Abstract | CrossRef Full Text | Google Scholar

Kumar, S., Fernando, D. J., Veves, A., Knowles, E. A., Young, M. J., and Boulton, A. J. (1991). Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res. Clin. Pract. 13, 63–67. doi:10.1016/0168-8227(91)90034-b

PubMed Abstract | CrossRef Full Text | Google Scholar

Lauria, G., Lombardi, R., Camozzi, F., and Devigili, G. (2009). Skin biopsy for the diagnosis of peripheral neuropathy. Histopathology 54, 273–285. doi:10.1111/j.1365-2559.2008.03096.x

PubMed Abstract | CrossRef Full Text | Google Scholar

LeCun, Y., Bengio, Y., and Hinton, G. (2015). Deep learning. Nature 521, 436–444. doi:10.1038/nature14539

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, Q., Zhong, Y., Zhang, T., Zhang, R., Zhang, Q., Zheng, H., et al. (2019). Quantitative analysis of corneal nerve fibers in type 2 diabetics with and without diabetic peripheral neuropathy: comparison of manual and automated assessments. Diabetes Res. Clin. Pract. 151, 33–38. doi:10.1016/j.diabres.2019.03.039

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, Y.-C., Lin, M. T.-Y., and Mehta, J. S. (2021a). Analysis of corneal nerve plexus in corneal confocal microscopy images. Neural Regen. Res. 16, 690–691. doi:10.4103/1673-5374.289435

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, Z., Lin, Y., Cao, Y., Hu, H., Wei, Y., Zhang, Z., et al. (2021b). Swin transformer: hierarchical vision transformer using shifted windows. doi:10.48550/arXiv.2103.14030

CrossRef Full Text | Google Scholar

Meng, Y., Preston, F. G., Ferdousi, M., Azmi, S., Petropoulos, I. N., Kaye, S., et al. (2023). Artificial intelligence based analysis of corneal confocal microscopy images for diagnosing peripheral neuropathy: a binary classification model. J. Clin. Med. 12, 1284. doi:10.3390/jcm12041284

PubMed Abstract | CrossRef Full Text | Google Scholar

Perkins, B. A., Lovblom, L. E., Lewis, E. J. H., Bril, V., Ferdousi, M., Orszag, A., et al. (2021). Corneal confocal microscopy predicts the development of diabetic neuropathy: a longitudinal diagnostic multinational consortium study. Diabetes Care 44, 2107–2114. doi:10.2337/dc21-0476

PubMed Abstract | CrossRef Full Text | Google Scholar

Petropoulos, I. N., Alam, U., Fadavi, H., Asghar, O., Green, P., Ponirakis, G., et al. (2013). Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care 36, 3646–3651. doi:10.2337/dc13-0193

PubMed Abstract | CrossRef Full Text | Google Scholar

Petropoulos, I. N., Alam, U., Fadavi, H., Marshall, A., Asghar, O., Dabbah, M. A., et al. (2014). Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy. Invest. Ophthalmol. Vis. Sci. 55, 2071–2078. doi:10.1167/iovs.13-13787

PubMed Abstract | CrossRef Full Text | Google Scholar

Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., et al. (2017). Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care 40, 136–154. doi:10.2337/dc16-2042

PubMed Abstract | CrossRef Full Text | Google Scholar

Preston, F. G., Meng, Y., Burgess, J., Ferdousi, M., Azmi, S., Petropoulos, I. N., et al. (2022). Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes. Diabetologia 65, 457–466. doi:10.1007/s00125-021-05617-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Pritchard, N., Edwards, K., Russell, A. W., Perkins, B. A., Malik, R. A., and Efron, N. (2015). Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes. Diabetes Care 38, 671–675. doi:10.2337/dc14-2114

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajesh, A. E., Davidson, O. Q., Lee, C. S., and Lee, A. Y. (2023). Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness. Diabetes Care 46, 1728–1739. doi:10.2337/dci23-0032

PubMed Abstract | CrossRef Full Text | Google Scholar

Richard, J.-L., Reilhes, L., Buvry, S., Goletto, M., and Faillie, J.-L. (2014). Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test. Int. Wound J. 11, 147–151. doi:10.1111/j.1742-481X.2012.01051.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Roszkowska, A. M., Licitra, C., Tumminello, G., Postorino, E. I., Colonna, M. R., and Aragona, P. (2021). Corneal nerves in diabetes-The role of the in vivo corneal confocal microscopy of the subbasal nerve plexus in the assessment of peripheral small fiber neuropathy. Surv. Ophthalmol. 66, 493–513. doi:10.1016/j.survophthal.2020.09.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Salahouddin, T., Petropoulos, I. N., Ferdousi, M., Ponirakis, G., Asghar, O., Alam, U., et al. (2021). Artificial intelligence-based classification of diabetic peripheral neuropathy from corneal confocal microscopy images. Diabetes Care 44, e151–e153. doi:10.2337/dc20-2012

PubMed Abstract | CrossRef Full Text | Google Scholar

Scarpa, F., Colonna, A., and Ruggeri, A. (2020). Multiple-image deep learning analysis for neuropathy detection in corneal nerve images. Cornea 39, 342–347. doi:10.1097/ICO.0000000000002181

PubMed Abstract | CrossRef Full Text | Google Scholar

Selvarajah, D., Kar, D., Khunti, K., Davies, M. J., Scott, A. R., Walker, J., et al. (2019). Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 7, 938–948. doi:10.1016/S2213-8587(19)30081-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Selvaraju, R. R., Cogswell, M., Das, A., Vedantam, R., Parikh, D., and Batra, D. (2020). Grad-CAM: visual explanations from deep networks via gradient-based localization. Int. J. Comput. Vis. 128, 336–359. doi:10.1007/s11263-019-01228-7

CrossRef Full Text | Google Scholar

Sloan, G., Selvarajah, D., and Tesfaye, S. (2021). Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat. Rev. Endocrinol. 17, 400–420. doi:10.1038/s41574-021-00496-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Sokolova, M., and Lapalme, G. (2009). A systematic analysis of performance measures for classification tasks. Inf. Process. Manag. 45, 427–437. doi:10.1016/j.ipm.2009.03.002

CrossRef Full Text | Google Scholar

Szegedy, C., Vanhoucke, V., Ioffe, S., Shlens, J., and Wojna, Z. (2016). Rethinking the inception architecture for computer vision. IEEE, 2818–2826. doi:10.1109/CVPR.2016.308

CrossRef Full Text | Google Scholar

Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., et al. (2010). Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293. doi:10.2337/dc10-1303

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, F., Zhang, J., Yu, J., Liu, S., Zhang, R., Ma, X., et al. (2017). Diagnostic accuracy of monofilament tests for detecting diabetic peripheral neuropathy: a systematic review and meta-analysis. J. Diabetes Res. 2017, 8787261–8787312. doi:10.1155/2017/8787261

PubMed Abstract | CrossRef Full Text | Google Scholar

Williams, B. M., Borroni, D., Liu, R., Zhao, Y., Zhang, J., Lim, J., et al. (2020). An artificial intelligence-based deep learning algorithm for the diagnosis of diabetic neuropathy using corneal confocal microscopy: a development and validation study. Diabetologia 63, 419–430. doi:10.1007/s00125-019-05023-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, F. X., Lee, P. S. Y., Yang, L., Gao, N., Zhang, Y., Ljubimov, A. V., et al. (2022). The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas. Prog. Retin. Eye Res. 89, 101039. doi:10.1016/j.preteyeres.2021.101039

PubMed Abstract | CrossRef Full Text | Google Scholar

Ziegler, D., Papanas, N., Zhivov, A., Allgeier, S., Winter, K., Ziegler, I., et al. (2014). Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 63, 2454–2463. doi:10.2337/db13-1819

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: confocal microscopy, convolutional neural network, diabetic neuropathy, Swin transformer network, deep learning

Citation: Chen W, Liao D, Deng Y and Hu J (2024) Development of a transformer-based deep learning algorithm for diabetic peripheral neuropathy classification using corneal confocal microscopy images. Front. Cell Dev. Biol. 12:1484329. doi: 10.3389/fcell.2024.1484329

Received: 21 August 2024; Accepted: 30 September 2024;
Published: 14 October 2024.

Edited by:

Weihua Yang, Jinan University, China

Reviewed by:

Jin Yuan, Sun Yat-sen University, China
Qi Dai, Wenzhou Medical University, China

Copyright © 2024 Chen, Liao, Deng and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jianzhang Hu, ophhjz@163.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.